Staff View: Who should be screened for primary aldosteronism? A comprehensive review of current evidence

Who should be screened for primary aldosteronism? A comprehensive review of current evidence

Arterial hypertension is a major risk factor for cardiovascular disease. The prevalence of primary aldosteronism (PA) ranges from 5% to 10% in the general hypertensive population and is regarded as one of the most common causes of secondary hypertension. There are two major causes of PA: bilateral a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huang, Wei Chieh, Lin, Yen Hung, Wu, Vin-Cent, Chen, Chen Huan, Siddique, Saulat, Chia, Yook Chin *, Tay, Jam Chin, Sogunuru, Guru Prasad, Cheng, Hao Min, Kario, Kazuomi
Format:	Article
Published:	Wiley 2022
Subjects:	QP Physiology RC Internal medicine
Online Access:	http://eprints.sunway.edu.my/3086/ https://doi.org/10.1111/jch.14558
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my.sunway.eprints.3086
record_format	eprints
spelling	my.sunway.eprints.30862024-08-12T09:40:23Z http://eprints.sunway.edu.my/3086/ Who should be screened for primary aldosteronism? A comprehensive review of current evidence Huang, Wei Chieh Lin, Yen Hung Wu, Vin-Cent Chen, Chen Huan Siddique, Saulat Chia, Yook Chin * Tay, Jam Chin Sogunuru, Guru Prasad Cheng, Hao Min Kario, Kazuomi QP Physiology RC Internal medicine Arterial hypertension is a major risk factor for cardiovascular disease. The prevalence of primary aldosteronism (PA) ranges from 5% to 10% in the general hypertensive population and is regarded as one of the most common causes of secondary hypertension. There are two major causes of PA: bilateral adrenal hyperplasia and aldosterone-producing adenoma. The diagnosis of PA comprises screening, confirmatory testing, and subtype differentiation. The Endocrine Society Practice Guidelines for the diagnosis and treatment of PA recommends screening of patients at an increased risk of PA. These categories include patients with stage 2 and 3 hypertension, drug-resistant hypertension, hypertensive with spontaneous or diuretic-induced hypokalemia, hypertension with adrenal incidentaloma, hypertensive with a family history of early onset hypertension or cerebrovascular accident at a young age, and all hypertensive first-degree relatives of patients with PA. Recently, several studies have linked PA with obstructive sleep apnea and atrial fibrillation unexplained by structural heart defects and/or other conditions known to cause the arrhythmia, which may be partly responsible for the higher rates of cardiovascular and cerebrovascular accidents in patients with PA. The aim of this review is to discuss which patients should be screened for PA, focusing not only on well-established guidelines but also on additional groups of patients with a potentially higher prevalence of PA, as has been reported in recent research. Wiley 2022 Article PeerReviewed Huang, Wei Chieh and Lin, Yen Hung and Wu, Vin-Cent and Chen, Chen Huan and Siddique, Saulat and Chia, Yook Chin * and Tay, Jam Chin and Sogunuru, Guru Prasad and Cheng, Hao Min and Kario, Kazuomi (2022) Who should be screened for primary aldosteronism? A comprehensive review of current evidence. The Journal of Clinical Hypertension, 24 (9). pp. 1194-1203. ISSN 0748-450X https://doi.org/10.1111/jch.14558 10.1111/jch.14558
institution	Sunway University
building	Sunway Campus Library
collection	Institutional Repository
continent	Asia
country	Malaysia
content_provider	Sunway University
content_source	Sunway Institutional Repository
url_provider	http://eprints.sunway.edu.my/
topic	QP Physiology RC Internal medicine
spellingShingle	QP Physiology RC Internal medicine Huang, Wei Chieh Lin, Yen Hung Wu, Vin-Cent Chen, Chen Huan Siddique, Saulat Chia, Yook Chin * Tay, Jam Chin Sogunuru, Guru Prasad Cheng, Hao Min Kario, Kazuomi Who should be screened for primary aldosteronism? A comprehensive review of current evidence
description	Arterial hypertension is a major risk factor for cardiovascular disease. The prevalence of primary aldosteronism (PA) ranges from 5% to 10% in the general hypertensive population and is regarded as one of the most common causes of secondary hypertension. There are two major causes of PA: bilateral adrenal hyperplasia and aldosterone-producing adenoma. The diagnosis of PA comprises screening, confirmatory testing, and subtype differentiation. The Endocrine Society Practice Guidelines for the diagnosis and treatment of PA recommends screening of patients at an increased risk of PA. These categories include patients with stage 2 and 3 hypertension, drug-resistant hypertension, hypertensive with spontaneous or diuretic-induced hypokalemia, hypertension with adrenal incidentaloma, hypertensive with a family history of early onset hypertension or cerebrovascular accident at a young age, and all hypertensive first-degree relatives of patients with PA. Recently, several studies have linked PA with obstructive sleep apnea and atrial fibrillation unexplained by structural heart defects and/or other conditions known to cause the arrhythmia, which may be partly responsible for the higher rates of cardiovascular and cerebrovascular accidents in patients with PA. The aim of this review is to discuss which patients should be screened for PA, focusing not only on well-established guidelines but also on additional groups of patients with a potentially higher prevalence of PA, as has been reported in recent research.
format	Article
author	Huang, Wei Chieh Lin, Yen Hung Wu, Vin-Cent Chen, Chen Huan Siddique, Saulat Chia, Yook Chin * Tay, Jam Chin Sogunuru, Guru Prasad Cheng, Hao Min Kario, Kazuomi
author_facet	Huang, Wei Chieh Lin, Yen Hung Wu, Vin-Cent Chen, Chen Huan Siddique, Saulat Chia, Yook Chin * Tay, Jam Chin Sogunuru, Guru Prasad Cheng, Hao Min Kario, Kazuomi
author_sort	Huang, Wei Chieh
title	Who should be screened for primary aldosteronism? A comprehensive review of current evidence
title_short	Who should be screened for primary aldosteronism? A comprehensive review of current evidence
title_full	Who should be screened for primary aldosteronism? A comprehensive review of current evidence
title_fullStr	Who should be screened for primary aldosteronism? A comprehensive review of current evidence
title_full_unstemmed	Who should be screened for primary aldosteronism? A comprehensive review of current evidence
title_sort	who should be screened for primary aldosteronism? a comprehensive review of current evidence
publisher	Wiley
publishDate	2022
url	http://eprints.sunway.edu.my/3086/ https://doi.org/10.1111/jch.14558
_version_	1808975639715250176
score	13.211869

Who should be screened for primary aldosteronism? A comprehensive review of current evidence

Similar Items